Arnaldo M Jimenez, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4700 Nelson Brogdon Blvd, Suite 200, Buford, GA 30518 Phone: 678-546-2929 Fax: 678-546-2921 |
News Archive
Early detection is key to more effective treatment for Alzheimer's disease and other forms of cognitive impairment, and new research shows that a test developed at the University of Tennessee is more than 95 percent effective in detecting cognitive abnormalities associated with these diseases.
MAP Pharmaceuticals, Inc. today announced new data from the FREEDOM-301 Phase 3 trial of its investigational LEVADEX orally inhaled migraine therapy showing low recurrence rates with LEVADEX. Eight additional analyses from the LEVADEX program also will be presented during the 2010 European Headache and Migraine Trust International Congress (EHMTIC) in Nice, France.
Critical Path Institute (C-Path) announced today that its Type 1 Diabetes (T1D) Consortium has received a positive response to its Letter of Intent (LOI) from the U.S. Food and Drug Administration (FDA) detailing the FDA's decision to accept the consortium's Biomarker Initiative project into the Center for Drug Evaluation and Research (CDER) Biomarker Qualification Program (BQP).
Sen. John Rockefeller, the Senate Finance Committee's number two Democrat, said Tuesday that he will not support Sen. Max Baucus' health reform bill "in its present form." Meanwhile, Senate Majority Leader Harry Reid plans to open debate on the bill by the end of September.
› Verified 7 days ago